I was happy with the AGM. They clearly are excited about OmniCar - and reinforcing the message that they are having a lot of discussions.
Unsurprising that we won’t get a readout of the ptx-100 trial until Q2 2021 (and same for Ptx-200 AML)
and I’m pleased that he went to some steps to address Ptx-200 ovarian and breast cancer. While i wouldn’t expect to see any real developments any time soon - at least they’re “in discussions now” about re pivoting both trials
Ann: AGM Presentation, page-11
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
-0.001(2.44%) |
Mkt cap ! $32.21M | |||
| Open | High | Low | Value | Volume |
| 4.1¢ | 4.1¢ | 4.0¢ | $15.83K | 392.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 704539 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 440771 | 4 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| PTX (ASX) Chart |